Retention Agreement between Galecto Biotech ApS and Hans Thalsgård Schambye
Galecto Biotech ApS and its CEO, Hans Thalsgård Schambye, have entered into a Retention Agreement. Under this agreement, the CEO will receive a retention bonus of DKK 2,173,800 if he remains employed through the earliest of December 31, 2025, a defined Sale Event, or termination without cause. The bonus is only payable if the CEO is employed at that time. The agreement is governed by Danish law and supplements the existing service agreement between the parties.
Exhibit 10.9
| ||
|
|
|
Retention Agreement | ||
|
GALECTO BIOTECH ApS
and
Hans Thalsgård Schambye
|
|
GALECTO BIOTECH ApS
CVR no. 34878366
Ole Maaløes Vej 3
2200 København N
(the "Company")
and
Hans Thalsgård Schambye
[Address]
(the "CEO")
(each a "Party" and collectively referred to as the "Parties")
have today entered into this Retention Agreement (the "Retention Agreement") relating to the service agreement between the Parties, dated 23 April 2013 (the “Service Agreement”).
Date: October 7, 2024
For GALECTO BIOTECH ApS
/s/ Carl Goldfischer
Carl Goldfischer, Chair of the Board of Galecto, Inc., parent company of Galecto Biotech ApS |
|
|
Date: October 7, 2024
/s/ Hans Schambye
Hans Thalsgård Schambye |